glp 1 agonist cardioprotective GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Glucagon-like peptide 1 receptor agonists:

Recently, multiple case reports and studies indicating safety risks for these medications and their use in patients planning to undergo general anesthesia have been published, as retained gastric contents can lead to intraoperative aspiration

The fascinating history of the GLP-1 drugs- Ozempic, Wegovy, and Mounjaro.

They modulate central neural pathways and peripheral metabolic processes, providing cardiometabolic benefits beyond weight reduction

Personalized GLP-1 medical weight loss programs

Pharmacovigilance analyses identified disproportionate reporting signals for dyspnoea and asthma-like events, particularly with exenatide, using the reporting odds ratio (ROR 2.14, 95% CI 1.882.43

It is recommended to take one capsule daily with food